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Although lymphatic complications after infrain-
guinal revascularization procedures involving the
groin are relatively uncommon, their management
can be problematic. In a recent series involving 2679
patients, an overall 1.2% incidence of lymphatic
complications was reported by Tyndall et al.1 Other
investigators have described an incidence of postop-
erative lymphoceles as high as 0.5%, while lymphor-
rhea was found in 2% of vascular incisions involving
the groin.2-5 The long-term complications of lym-
phatic leaks involve a risk of vascular graft infections
and extended hospital stays.3
Some authors have advocated a conservative ini-
tial approach toward postoperative lymphatic com-
plications consisting principally of bed rest, prophy-
lactic antibiotics, and pressure dressings.2,6 This
approach is based on there being an eventual closure
of most such leaks. Extended hospital lengths of
stay, increased costs, patient immobility, and risk of
underlying graft infection, however, are significant
disadvantages to this mode of treatment. Early sur-
gical intervention for lymphorrhea and lymphoceles
shortens hospital length of stay and lowers the inci-
dence of both graft and wound infection.1,4,7 The
biggest technical challenge in the operative repair of
such complications has been the identification of the
causative open lymphatic channels. The use of vital
dyes for the identification of these injured lymphat-
ic channels has been proposed as a simple and reli-
able method before the exploration of the groin.2,7,8
We, along with other investigators, however, have
not always found the distal injection of vital dyes
into the web spaces of the foot to be successful in
pinpointing the proximal femoral site of lymphatic
disruption.5 We present a helpful modification of the
vital dye technique involving proximal thigh injec-
tion for the diagnosis of groin lymphatic disruption.
This technique is faster and appears to be more suc-
cessful than the original methodology.
CASE REPORT
A 59-year-old white male was referred from another
institution 2 months after a left femoral-to-peroneal in situ
saphenous vein bypass grafting procedure was performed
for toe gangrene caused by atheroembolization. The post-
operative course was complicated by distal leg wound dis-
ruption with infection and severe leg swelling. In addition,
the patient had a 10-cm groin lymphocele that had begun
to drain through a disruption of the femoral incision. The
bypass graft was patent although there was an arterial-
venous fistula identified in the distal thigh. The ankle-
brachial index was 0.75, and there was diminished pulsatili-
ty and amplitudes of less than 5 mm in all digits on photo-
plethysmographic evaluation. The patient was admitted for
broad-spectrum intravenous antibiotics for his lower leg
wound infection and cellulitis. This condition improved,
but the patient refused surgical intervention for the lym-
phocele and lymphorrhea. He underwent treatment as an
outpatient for 6 weeks, with wound packing with 1⁄2-inch
iodine-impregnated gauze and oral erythromycin antibi-
otics for methicillin resistant Staphylococcus aureus found on
culture of the lymphatic drainage. Although the lymphocele
diminished significantly in size, the lymphorrhea persisted
and the patient subsequently consented to surgical repair.
A 0.5-mL, 1% solution of isosulfan blue (Lymphazurin;
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Hirsch Industries, Richmond, Va) was injected intradermal-
ly 30 minutes before surgery. Because of impaired forefoot
and toe perfusion, along with the associated toe gangrene,
the injection was made into the distal dorsum of the foot
rather than in the web space of the toes. By the time of
surgery, there was no evidence of dye within the groin
wound. Further injections into the foot were believed to
put the patient at significant risk of later skin necrosis and
breakdown. Therefore, a 1-mL intradermal injection of iso-
sulfan blue was administered onto the anterior aspect of the
mid thigh with a 25-gauge needle (Fig 1). There was visible
uptake into the superficial lymphatic channels within 3 min-
utes. Within 5 minutes, extravasation of dye was seen from
the lymphocele. With the visualization provided by the blue
dye, circumferential dissection around the 2-cm lymphocele
was performed. The adjoining subcutaneous tissues were
not discolored, and there was easy visibility of both the lym-
phocele and the draining lymphatic channel (Fig 2). The
lymphocele was resected, the channel suture ligated, the
incision closed, and the patient discharged the following
morning. Two weeks later, the arterial-venous fistula was
electively ligated and toes 1 through 4 were amputated with
good subsequent healing of the amputation sites.
DISCUSSION
Lower extremity edema after arterial reconstruc-
tive surgery is commonly seen after femoral-popliteal
or tibial bypass grafting procedures and has been
ascribed to interference of lymphatic drainage.9
Postoperative groin lymphatic complications appear
to be more directly related to the disruption of friable
Fig 1. Three minutes after injection into the anterior mid thigh region (arrow), there is
marked upward cephalad progression of dye toward groin within intradermal lymphatics.
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perivascular lymphatic channels of either the superfi-
cial or deep lymphatic systems.1,10,11 Dissection of
the femoral vessels, reoperation, diabetes, advanced
age, surgery for limb salvage, and distal leg infection
have all been associated with increased risk for devel-
opment of lymphorrhea or lymphoceles.3,5,6 Graft
infection, although rare, is the complication of great-
est concern. Resolution of lymphorrhea has been
reported in most patients who undergo conservative
nonoperative therapy, but protracted lymphatic
drainage may occur, especially in the presence of
prosthetic grafts.3,6 Kwaan et al4 reported serious
wound infections in three of seven patients, and in
another series of 41 patients, Tyndall et al1 found five
wound infections in those patients treated without
surgery, with one patient requiring amputation after
prosthetic graft infection. On the basis of such poten-
tial complications and the prolonged morbidity and
costs of conservative therapy, most surgeons now
advocate repair of lymphatic fistulas.4,5,7
Surgical repair is not always simple in these cir-
cumstances. Although lymphoceles may have a visi-
ble lymphatic opening when examined with magni-
fication, this is not invariably the case. Lymphorrhea
alone, without the formation of a defined lympho-
cele, also makes the identification and dissection of
the offending disrupted lymphatic channels difficult.
This is particularly true in patients who have under-
Fig 2. After surgical dissection of area, remnant 2-cm lymphocele (arrow) is opened showing
blue staining within its cavity. Of note, there is no associated staining of surrounding subcuta-
neous tissues.
gone reoperative surgery and have much scarring in
their groin. For these reasons, attempts were made
to better identify the sites of lymphatic disruption.
Lymphangiograms were first used with intralym-
phatic injection of iodized oils. This was rather inva-
sive, however, and necessitated the sometimes diffi-
cult direct cannulation of a lymphatic vessel on 
the dorsum of the foot. Lymphoscintigraphy, with
either 99mTechnetium sulphide colloid or albumin,
allows both a morphometric and functional assess-
ment of lymphatic flow in a less invasive manner.11-
13 This procedure, however, cannot be easily per-
formed in the operating room.
Kwaan et al4 first described the use of Evans blue
vital dye injected intradermally between the web
spaces of the foot for groin lymphatic leak identifi-
cation. Subsequently, the injection of isosulfan blue
has proved to be more efficacious for this purpose
because of its more rapid absorption and ease of use.
Isosulfan blue is a water-soluble dye capable of
delineating both superficial and deep lymphatic
channels. It is taken up much more rapidly by lym-
phatics and can be injected subcutaneously and
intradermally. In addition, it does not stain sur-
rounding tissues on extravasation from an open lym-
phatic channel. On identification of a leak, the
involved vessel can be ligated with absorbable suture
and the incision can be closed in multiple layers.4,14
If a lymphocele is also present, the definitive treat-
ment includes the excision of the pseudocapsule
with the obliteration of the cavity and multiple tissue
layer reapproximation.
Most complications involving vital dyes have
been reported in their use for lymphangiography,
although adverse reactions are seen in less than 0.2%
of patients overall.15 Miscellaneous blue dyes with
variable lymphatic selectivity (Evans blue, methylene
blue) had been marketed before 1938 and had not
been reviewed for safety and efficacy by the Food
and Drug Administration.15 The patent blue dyes
(Patent Blue V, VF, alphazurine 2G) and isosulfan
blue are triphenylmethane dyes and provide selective
lymphatic visualization. They may cause variable
degrees of skin necrosis and possible anaphylactic
reactions at high concentrations, and, for this rea-
son, a maximal dye concentration of 1% is recom-
mended to avoid these complications.15-19 Most of
these water-soluble food colorings have variable lipid
solubilities and potentials for local tissue injury and
cellular damage that have not been extensively stud-
ied.16,18,19 Patent blue dye is still being used in sen-
tinel lymph node localization for malignant dis-
ease.20 Isosulfan blue for the identification of lym-
phatic vessels has been prospectivley evaluated in a
clinical trial involving 543 patients.15 It was found to
be safe and efficacious in the performance of lym-
phangiograms, with mild allergic reactions occurring
in only 0.9% of patients. Because of this large and
documented clinical experience, it is recommended
as the dye of choice at this time.
Lymphatic transport of dye to the groin after
injection in the foot is dependent on the superficial
lymphatic system.11,21 Because of the medial course
of these superficial lymphatics at the knee, at mid
thigh, and in the groin, they may be disrupted dur-
ing reconstructive arterial surgery and vein harvest-
ing. Postoperative pedal dye injection may therefore
not be effectively transported proximally to the
groin, as in our patient. Dissatisfaction with vital dye
use is most commonly the result of such inadequate
staining of lymphatic channels at their leak sites. It is
for this reason that some investigators have suggest-
ed wound exploration without adjunctive vital dye
injection.1 To improve visibility, vigorous thigh and
calf massage for dye movement proximally from the
foot has also been recommended. There has been
one report of dislodgement of a deep venous throm-
bus leading to pulmonary embolization after such an
attempt.1 We have found that isosulfan blue injection
into the mid thigh, a technique also briefly men-
tioned by Lewis and Wolf22 as multiple subcutaneous
blebs with a patent blue dye, provides improved lym-
phatic staining as compared with the traditional dis-
tal pedal injection technique. In the thigh, lymphatic
flow commonly occurs from the superficial to the
deep system, and dye injection in this region may
more easily reach disrupted deeper lymphatic chan-
nels.21 This may also explain another important
advantage of proximal injection—the reduction in
dye transit time. The average time for the dye to trav-
el from a pedal intradermal injection to the femoral
leak site is said to be within 15 minutes.14,15 We saw
a significantly more rapid transport of isosulfan blue
to the target site within 5 minutes, thus allowing
injection of the patient within the operating room in
a painless manner after anesthesia had been induced.
No manipulative effort with thigh or calf compres-
sion was necessary. The improved visualization is
attributed to the selectivity of isosulfan blue for lym-
phatic channels and faster and more direct access into
the proximal superficial and deep lymphatic channels,
which allow a higher volume of vital dye to reach the
groin. In addition, as in our patient, there would be
no associated concern for possible skin necrosis as the
result of poor perfusion and ischemic tissue distally
on the dorsum of the foot.
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This modification of an accepted diagnostic tech-
nique used for postoperative groin exploration will
assist in the treatment of those patients who experi-
ence such infrequent but troublesome lymphatic
complications.
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